Turner BE - Search Results

1

Mesenchymal stromal cells transiently alter the inflammatory milieu post-transplant to delay graft-versus-host disease.

Christensen ME, Turner BE, Sinfield LJ, Kollar K, Cullup H, Waterhouse NJ, Hart DN, Atkinson K, Rice AM. Christensen ME, et al. Among authors: turner be. Haematologica. 2010 Dec;95(12):2102-10. doi: 10.3324/haematol.2010.028910. Epub 2010 Aug 26. Haematologica. 2010. PMID: 20801899 Free PMC article.

2

Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease.

Turner BE, Kambouris ME, Sinfield L, Lange J, Burns AM, Lourie R, Atkinson K, Hart DN, Munster DJ, Rice AM. Turner BE, et al. Transplantation. 2008 Oct 15;86(7):968-76. doi: 10.1097/TP.0b013e3181874787. Transplantation. 2008. PMID: 18852664

3

Reduced intensity conditioning for hematopoietic stem cell transplantation: has it achieved all it set out to?

Turner BE, Collin M, Rice AM. Turner BE, et al. Cytotherapy. 2010 Jul;12(4):440-54. doi: 10.3109/14653241003709678. Cytotherapy. 2010. PMID: 20345215 Review.

4

Regulatory T cells inhibit CD8(+) T-cell tissue invasion in human skin graft-versus-host reactions.

Mavin E, Ahmed SS, O'Boyle G, Turner B, Douglass S, Norden J, Collin M, Ali S, Dickinson A, Wang XN. Mavin E, et al. Transplantation. 2012 Sep 15;94(5):456-64. doi: 10.1097/TP.0b013e31826205d6. Transplantation. 2012. PMID: 22890131

5

Elevated level of HSPA1L mRNA correlates with graft-versus-host disease.

Atarod S, Turner B, Pearce KF, Ahmed SS, Norden J, Bogunia-Kubik K, Wang XN, Collin M, Dickinson AM. Atarod S, et al. Transpl Immunol. 2015 Jun;32(3):188-94. doi: 10.1016/j.trim.2015.02.002. Epub 2015 Feb 11. Transpl Immunol. 2015. PMID: 25680846

6

A multifaceted approach to global health.

Schiebinger L, Turner BE, Laxminarayan R, Fanzo J, Cluver L, Ibrahim M. Schiebinger L, et al. Among authors: turner be. Med. 2024 Apr 12;5(4):271-274. doi: 10.1016/j.medj.2024.03.005. Epub 2024 Mar 28. Med. 2024. PMID: 38552630

7

Neuro-oncology clinical trial locations and social vulnerability in the United States.

Gomez GT, Turner BE, Redmond KJ, Deville C Jr, Perni S. Gomez GT, et al. Among authors: turner be. Neurooncol Pract. 2023 Oct 20;11(1):100-102. doi: 10.1093/nop/npad062. eCollection 2024 Feb. Neurooncol Pract. 2023. PMID: 38222050 Free article. No abstract available.

8

Underrepresentation of racial and ethnic minority groups in gynecologic oncology: An analysis of over 250 trials.

Richardson MT, Barry D, Steinberg JR, Thirunavu V, Strom DE, Holder K, Zhang N, Turner BE, Magnani CJ, Weeks BT, Young AMP, Lu CF, Wolgemuth TR, Laasiri N, Squires NA, Anderson JN, Karlan BY, Chan JK, Kapp DS, Roque DR, Salani R. Richardson MT, et al. Among authors: turner be. Gynecol Oncol. 2024 Feb;181:1-7. doi: 10.1016/j.ygyno.2023.12.001. Epub 2023 Dec 13. Gynecol Oncol. 2024. PMID: 38096673

9

Obstetric Clinical Trial Diversity: Analysis of Trial Focus and Representation From 2007 to 2020.

Steinberg JR, DiTosto JD, Turner BE, Roque DR, Yee LM. Steinberg JR, et al. Among authors: turner be. Obstet Gynecol. 2023 Oct 1;142(4):840-843. doi: 10.1097/AOG.0000000000005330. Epub 2023 Sep 7. Obstet Gynecol. 2023. PMID: 37678886 Free PMC article.

10

Using Unsupervised Machine Learning as an Alternative to Curated Medical School Rankings.

Turner BE. Turner BE. JAMA Netw Open. 2023 Jul 3;6(7):e2324100. doi: 10.1001/jamanetworkopen.2023.24100. JAMA Netw Open. 2023. PMID: 37462975 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

51 results

Search Page